VANCOUVER, Jan. 16, 2013 /PRNewswire/ - Abattis Bioceuticals Corp. (the
"Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces it has
been granted Intl Class 5 Trademark for DefenZall in Taiwan and the
Mr. Mike Withrow, Chief Executive Officer on behalf of the Company,
stated, "We are pleased to extend the intellectual property of the
company as we grow our brands. This mark will be used to brand our
proprietary Anti-Viral Nutraceutical Platform of products which are;
DefenZall Daily, DefenZall Immune Support and DefenZall Serious
Defense They will be launched through our Canadian distributor Hedley
Enterprises, on the Internet and via our Distributor in Hong Kong."
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company with
capabilities through its wholly owned subsidiaries of producing,
licensing and marketing proprietary ingredients and bio-similar
compounds for use in Pharmaceuticals, Nutraceutical, Cosmetic and
Animal Nutrition markets. The company owns the exclusive world wide
rights to the Vertical Designs Advanced Automated Growing Technologies
for these markets. The company also has a deep pipeline of proprietary
products ready for sale in high growth areas of Functional Foods and
Supplements business. For more information, visit the Company's website
ON BEHALF OF THE BOARD
Michael Withrow, President & CEO
Neither the CNSX Exchange nor its regulations services accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Abattis Bioceuticals Corp.